Lishengpharma
00239314.240.92% ( +0.13 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Lishengpharma(002393) the Revenue is 332.28 M (-10.16%);the EBIT is 51.38 M (+42.96%);the EPS is 0.167 (-4.74%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.33B10.16%
----
----
EBIT
0.05B42.96%
----
----
EPS
0.16674.74%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf